Announcements Trials
Browse Landscape

Phase

Phase 1/2 10Phase 1 9Phase 2 7Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 18OTHER_GOV 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Mammography 12Radiofrequency Ablation 9Blood Specimen Collection 9Standard of Care 8Drug Delivery Systems 8Colonoscopy 8Uterine Myomectomy 6Robotic Surgical Procedures 6Cryosurgery 6Colposcopy 6Biopsy 6Proton Therapy 5Inositol 5Therapeutics 4Surgical Procedures, Operative 4Radiotherapy 4Leukapheresis 4Food 4Drug Therapy 4Cryotherapy 4Cisplatin 4CF regimen 4Brachytherapy 4pegylated granulocyte colony-stimulating factor 3exemestane 3epigallocatechin gallate 3Uterine Artery Embolization 3Sunitinib 3Paclitaxel 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Immune Checkpoint Inhibitors × Clear all
NCT06190275 2026-04-24

Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

Grit Biotechnology

Phase NA Recruiting
32 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡